# Pep2Tango Therapeutics, Inc. — Form D

Pep2Tango Therapeutics, Inc. of POTOMAC, MD, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-21. The offering totals $16.7M, of which $16.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-11-21
- Form: D
- Accession: 0002040766-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $16.7M
- Amount sold: $16.7M
- Investors: 12
- Date of first sale: 2024-09-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-530055

## Issuer

- Name: Pep2Tango Therapeutics, Inc.
- CIK: 0002040766
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 12050 WETHERFIELD LANE, POTOMAC, MD, 20854
- Phone: 703.201.2978

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Soumitra Ghosh | Director | Potomac, MD |
| Mickey Kim | Director | Potomac, MD |
| Carlo Rizzuto | Director | Littleton, CO |
| Cristina Rondinone | Director | Potomac, MD |
| Cristina Rondinone | Executive Officer | Potomac, MD |

## More

- [CIK 2040766 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2040766&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002040766-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.